IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,348,717 | -4.0% | 39,174,000 | 0.0% | 0.43% | -9.3% |
| Q2 2023 | $39,966,498 | +8.0% | 39,174,000 | +6.5% | 0.47% | +8.2% |
| Q1 2023 | $37,005,818 | +56.6% | 36,774,000 | +71.1% | 0.44% | +78.8% |
| Q4 2022 | $23,632,820 | +7.8% | 21,495,000 | 0.0% | 0.24% | +3.8% |
| Q3 2022 | $21,916,000 | +77.3% | 21,495,000 | +87.0% | 0.24% | +90.3% |
| Q2 2022 | $12,364,000 | +13.7% | 11,495,000 | +24.7% | 0.12% | +17.0% |
| Q1 2022 | $10,874,000 | +4.1% | 9,221,000 | +0.4% | 0.11% | +9.3% |
| Q4 2021 | $10,442,000 | +764.4% | 9,181,000 | +818.1% | 0.10% | +870.0% |
| Q3 2021 | $1,208,000 | +0.8% | 1,000,000 | 0.0% | 0.01% | +11.1% |
| Q2 2021 | $1,198,000 | +5.8% | 1,000,000 | 0.0% | 0.01% | -10.0% |
| Q1 2021 | $1,132,000 | 0.0% | 1,000,000 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $1,132,000 | +15.7% | 1,000,000 | 0.0% | 0.01% | -11.1% |
| Q3 2020 | $978,000 | – | 1,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAMDEN ASSET MANAGEMENT L P /CA | 36,225,000 | $40,606,000 | 1.41% |
| Context Capital Management, LLC | 3,000,000 | $3,378,000 | 0.46% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,808,000 | $4,308,000 | 0.45% |
| AQR Arbitrage LLC | 7,500,000 | $8,444,000 | 0.30% |
| Polar Asset Management Partners Inc. | 14,500,000 | $16,367,000 | 0.18% |
| LINDEN ADVISORS LP | 9,300,000 | $10,496,000 | 0.08% |
| Calamos Advisors LLC | 9,500,000 | $10,688,000 | 0.06% |
| Jefferies Group LLC | 2,201,000 | $2,502,527 | 0.02% |
| Citadel Advisors | 62,788,000 | $71,391,000 | 0.02% |
| LAZARD ASSET MANAGEMENT LLC | 10,000,000 | $11,259,000 | 0.01% |